Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Ralaniten triacetate | 1637573-04-6 | 98.8% | 521.00 | C27H33ClO8 | 25MG
Supplier: Medchemexpress LLC HY123875A25MG
Ralaniten triacetate is an orally active androgen receptor (AR) N-terminal domain (NTD) inhibitor used for preclinical research. It functions as a pro-agent of ralaniten, inhibiting AR transcriptional activity and showing activity against full-length and resistance-related AR species, including AR-v7. Consult the supplier documentation for handling, storage, purity, and safety information.
- First-in-class AR N-terminal domain inhibition.
- Active against full-length and resistant AR species such as AR-v7.
- Inhibits AR transcriptional activity.
- Suitable for research into castration-resistant prostate cancer models.
- Supplied with certificate of analysis and safety data sheet for quality verification.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?